GSK has a challenging and inspiring mission: to improve the
quality of human life by enabling people to do more, feel better
and live longer. This mission gives us the purpose to develop
innovative medicines and products that help millions of people
around the world.
We are one of the few pharmaceutical companies researching both
medicines and vaccines for the World Health Organization's three
priority diseases - HIV/AIDS, tuberculosis and malaria, and are
very proud to have developed some of the leading global medicines
in these fields.
Headquartered in the UK and with operations based in the US, we
are one of the industry leaders, with an estimated seven per cent
of the world's pharmaceutical market.
But being a leader brings responsibility. This means that we care
about the impact that we have on the people and places touched by
our mission to improve health around the world.
It also means that we must help developing countries where
debilitating disease affects millions of people and access to
life-changing medicines and vaccines is a problem. To meet this
challenge, we are committed to providing discounted medicines where
they are needed the most.
As a company with a firm foundation in science, we have a flair
for research and a track record of turning that research into
powerful, marketable drugs.
We produce medicines that treat major disease areas such as asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer.
We also market other products, many of which are among the market leaders:
- over-the-counter (OTC) medicines
- dental products
- smoking control products
- nutritional healthcare drinks
- skincare products marketed by Stiefel Laboratories?

